The total return over the past 12 months is -77.00% vs. +16.94% for the S&P 500. So far it's up -52.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (77.00%) | (80.18%) | (83.90%) | N/A | N/A | N/A |
| Total Return CAGR | (77.00%) | (80.18%) | (83.90%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Dermata Therapeutics, Inc. (DRMA)
| Year | Start price | End price | DRMA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.32 | $1.11 | (52.16%) | +14.51% | (66.67%) |
| 2025 | $13.50 | $2.32 | (82.81%) | +17.72% | (100.53%) |
| 2024 | $91.50 | $13.50 | (85.25%) | +24.89% | (110.14%) |
| 2023 | $981.60 | $91.50 | (90.68%) | +26.19% | (116.87%) |
| 2022 | $4,176.00 | $981.60 | (76.49%) | (18.17%) | (58.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
